Author

Jianjun Cheng

ShanghaiTech UniversityPrimary ORCID profile (0000-0003-2561-9291 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Jianjun ChengiD1 paper · Westlake University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Chao XuiD· 1 shared Dongliang XuiD· 1 shared Fang BaiiD· 1 shared Gaofeng FaniD· 1 shared Jiawei YaniD· 1 shared Jing CheniD· 1 shared Kaixuan DiaoiD· 1 shared Lu LiuiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Chao XuORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Tumor hypoxia adaptation depends on FLAD1 mediated mitochondrial metabolic reprogramming

Xiangyu Zhao, Tao Wu, Sanan Wu, Yujin Chen, Yu Zhang, Jing Chen, Kaixuan Diao, Zaoke He, Jiawei Yan, Tianzhu Lu, Chao Xu, Lu Liu, Gaofeng Fan, Dongliang Xu, Xinxiang Li, , Xuesong Liu

The paper identifies FLAD1 as a key gene for hypoxia adaptation in tumors and develops a deep learning model to predict hypoxia-dependent metabolic genes.

bioRxiv · Mar 5, 2025 · PreprintCancer Biology